Alps Advisors Inc Albireo Pharma, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$18.01 - $23.78 $59,613 - $78,711	3,310 Added 30.8%	14,058 $303,000
Q3 2022 Nov 14, 2022	SELL	$16.32 - $26.37 $14,100 - $22,783	-864 Reduced 7.44%	10,748 $208,000
Q2 2022 Aug 11, 2022	SELL	$18.54 - $37.29 $153,659 - $309,059	-8,288 Reduced 41.65%	11,612 $231,000
Q1 2022 May 16, 2022	SELL	$23.94 - $33.74 $57,623 - $81,212	-2,407 Reduced 10.79%	19,900 $594,000
Q4 2021 Feb 09, 2022	SELL	$21.19 - $31.29 $27,292 - $40,301	-1,288 Reduced 5.46%	22,307 $520,000
Q3 2021 Nov 15, 2021	SELL	$27.36 - $35.98 $45,964 - $60,446	-1,680 Reduced 6.65%	23,595 $736,000
Q2 2021 Aug 11, 2021	SELL	$28.9 - $36.87 $268,943 - $343,112	-9,306 Reduced 26.91%	25,275 $889,000
Q1 2021 May 07, 2021	BUY	$32.03 - $42.85 $8,199 - $10,969	256 Added 0.75%	34,581 $1.22 Million
Q4 2020 Feb 03, 2021	BUY	$31.56 - $42.16 $319,071 - $426,237	10,110 Added 41.75%	34,325 $1.29 Million
Q3 2020 Nov 04, 2020	BUY	$23.19 - $41.61 $87,727 - $157,410	3,783 Added 18.52%	24,215 $808,000
Q2 2020 Aug 05, 2020	SELL	$14.82 - $29.92 $90,327 - $182,362	-6,095 Reduced 22.98%	20,432 $541,000
Q1 2020 May 06, 2020	BUY	$11.67 - $27.23 $8,997 - $20,994	771 Added 2.99%	26,527 $434,000
Q4 2019 Feb 07, 2020	BUY	$16.92 - $28.96 $7,072 - $12,105	418 Added 1.65%	25,756 $655,000
Q3 2019 Nov 04, 2019	BUY	$20.0 - $31.88 $2,960 - $4,718	148 Added 0.59%	25,338 $507,000
Q2 2019 Aug 07, 2019	SELL	$30.67 - $37.86 $114,153 - $140,914	-3,722 Reduced 12.87%	25,190 $812,000
Q1 2019 May 01, 2019	BUY	$22.22 - $32.21 $27,841 - $40,359	1,253 Added 4.53%	28,912 $931,000
Q4 2018 Feb 04, 2019	BUY	$20.9 - $32.57 $135,390 - $210,988	6,478 Added 30.58%	27,659 $678,000
Q3 2018 Oct 25, 2018	BUY	$29.29 - $36.87 $114,933 - $144,677	3,924 Added 22.74%	21,181 $698,000
Q2 2018 Aug 02, 2018	BUY	$28.9 - $37.31 $498,727 - $643,858	17,257 New	17,257 $613,000

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account